Envisia Therapeutics' Convertible Note Round

Envisia Therapeutics raised a round of funding on October 19, 2015.

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powe…

Articles about Envisia Therapeutics' Convertible Note Round: